ArticleJAMA oncology2020
What Constitutes a Valid Surrogate End Point in Cancer Clinical Trials?
Yu Shyr et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this papercites it
ArticleJAMA oncology2020
Yu Shyr et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.